Recently, DHX9 has been found to participate in the recruitment of BRCA1 to RNA and promote DNA end resection in homologous recombination (39), as well as prevent R-loop-associated DNA damage and be overexpressed in cancer (40). Here, BRCA1 is linked to cancer.